Pharmacology, Biodistribution, and Efficacy of GPCR-Based Pepducins in Disease Models

Methods in Molecular Biology

Volumn 683, Issue , 2011, Pages 259-275

  Tressel, Sarah L ^a   Koukos, Georgios ^a   Tchernychev, Boris ^a   Jacques, Suzanne L ^a   Covic, Lidija ^b   Kuliopulos, Athan ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cancer; CXCR1; CXCR2; CXCR4; GPCR; Inflammation; PAR1; PAR4; Pepducin; Sepsis; Thrombosis

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LIPOPEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENERAL ASPECTS OF DISEASE; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TRANSPORT; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; DISEASE; HUMANS; LIPOPEPTIDES; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED;

MLCS; MLOWN;

EID: 79551584772     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-919-2_19     Document Type: Chapter

References (48)

1. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor, Science 289, 739–745.
2. Covic, L., Misra, M., Badar, J., Singh, C., and Kuliopulos, A. (2002) Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation, Nat Med 8, 1161–1165.
3. Kuliopulos, A., and Covic, L. (2003) Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis, Life Sci 74, 255–262.
4. Covic, L., Gresser, A. L., Talavera, J., Swift, S., and Kuliopulos, A. (2002) Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides, Proc Natl Acad Sci USA 99, 643–648.
5. Keuren, J. F., Wielders, S. J., Ulrichts, H., Hackeng, T., Heemskerk, J. W., Deckmyn, H., Bevers, E. M., and Lindhout, T. (2005) Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1, Arterioscler Thromb Vasc Biol 25, 1499–1505.
6. Leger, A. J., Jacques, S. L., Badar, J., Kaneider, N. C., Derian, C. K., Andrade-Gordon, P., Covic, L., and Kuliopulos, A. (2006) Blocking the protease-activated receptor 1–4 heterodi-mer in platelet-mediated thrombosis, Circulation 113, 1244–1254.
7. Trivedi, V., Boire, A., Tchernychev, B., Kaneider, N. C., Leger, A. J., O’Callaghan, K., Covic, L., and Kuliopulos, A. (2009) Platelet matrix metalloprotease-1 mediates thrombo-genesis by activating PAR1 at a cryptic ligand site, Cell 137, 332–343.
8. Majumdar, M., Tarui, T., Shi, B., Akakura, N., Ruf, W., and Takada, Y. (2004) Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9) beta(1), J Biol Chem 279, 37528–37534.
9. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., and Kuliopulos, A. (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells, Cell 120, 303–313.
10. Remsberg, J. R., Lou, H., Tarasov, S. G., Dean, M., and Tarasova, N. I. (2007) Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth, J Med Chem 50, 4534–4538.
11. Kaneider, N. C., Agarwal, A., Leger, A. J., and Kuliopulos, A. (2005) Reversing systemic inflammatory response syndrome with chemokine receptor pepducins, Nat Med 11, 661–665.
12. Kaneider, N. C., Leger, A. J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L., and Kuliopulos, A. (2007) ‘Role reversal’ for the receptor PAR1 in sepsis-induced vascular damage, Nat Immunol 8, 1303–1312.
13. Licht, T., Tsirulnikov, L., Reuveni, H., Yarnitzky, T., and Ben-Sasson, S. A. (2003) Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3), Blood 102, 2099–2107.
14. Edwards, R. J., Moran, N., Devocelle, M., Kiernan, A., Meade, G., Signac, W., Foy, M., Park, S. D., Dunne, E., Kenny, D., and Shields, D. C. (2007) Bioinformatic discovery of novel bioactive peptides, Nat Chem Biol 3, 108–112.
15. Shpakov, A. O., Pertseva, M. N., Guryanov, I. A., and Vlasov, G. P. (2005) Influence of synthetic peptides derived from the third cytoplasmic loop of the type 1 relaxin receptor on the stimulation of G-protein GTP-binding activity by relaxin, Biol Membrany 22, 450–457.
16. Swift, S., Leger, A. J., Talavera, J., Zhang, L., Bohm, A., and Kuliopulos, A. (2006) Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism, J Biol Chem 281, 4109–4116.
17. Shpakov, A. O., Gur’yanov, I. A., Kuznetsova, L. A., Plesneva, S. A., Shpakova, E. A., Vlasov, G. P., and Pertseva, M. N. (2007) Studies of the molecular mechanisms of action of relaxin
18. Wielders, S. J., Bennaghmouch, A., Reutelingsperger, C. P., Bevers, E. M., and Lindhout, T. (2007) Anticoagulant and anti-thrombotic properties of intracellular protease-activated receptor antagonists, J Thromb Haemost 5, 571–576.
19. Covic, L., Tchernychev, B., Jacques, S., and Kuliopulos, A. (2007) Pharmacology and In Vivo Efficacy of Pepducins in Hemostasis and Arterial Thrombosis, in Handbook of Cell-Penetrating Peptides (Langel, U., Ed.), pp. 245–257, CRC Press, Boca Raton, FL.
20. Hollenberg, M. D., Saifeddine, M., Sandhu, S., Houle, S., and Vergnolle, N. (2004) Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo, Br J Pharmacol 143, 443–454.
21. Slofstra, S. H., Bijlsma, M. F., Groot, A. P., Reitsma, P. H., Lindhout, T., ten Cate, H., and Spek, C. A. (2007) Protease-activated receptor-4 inhibition protects from multior-gan failure in a murine model of systemic inflammation, Blood 110, 3176–3182.
22. Houle, S., Papez, M. D., Ferazzini, M., Hollenberg, M. D., and Vergnolle, N. (2005) Neutrophils and the kallikrein–kinin system in proteinase-activated receptor 4-mediated inflammation in rodents, Br J Pharmacol 146, 670–678.
23. Zhang, G., Kernan, K. A., Collins, S. J., Cai, X., Lopez-Guisa, J. M., Degen, J. L., Shvil, Y., and Eddy, A. A. (2007) Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals, J Am Soc Nephrol 18, 846–859.
24. Annahazi, A., Gecse, K., Dabek, M., Ait-Belgnaoui, A., Rosztoczy, A., Roka, R., Molnar, T., Theodorou, V., Wittmann, T., Bueno, L., and Eutamene, H. (2009) Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice, Pain 144, 209–217.
25. Dabek, M., Ferrier, L., Roka, R., Gecse, K., Annahazi, A., Moreau, J., Escourrou, J., Cartier, C., Chaumaz, G., Leveque, M., Ait-Belgnaoui, A., Wittmann, T., Theodorou, V., and Bueno, L. (2009) Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis, Am J Pathol 175, 207–214.
26. McDougall, J. J., Zhang, C., Cellars, L., Joubert, E., Dixon, C. M., and Vergnolle, N. (2009) Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice, Arthritis Rheum 60, 728–737.
27. Hotchkiss, R. S., and Karl, I. E. (2003) The pathophysiology and treatment of sepsis, N Engl J Med 348, 138–150.
28. Riedemann, N. C., Guo, R. F., and Ward, P. A. (2003) Novel strategies for the treatment of sepsis, Nat Med 9, 517–524.
29. Sambrano, G. R., Weiss, E. J., Zheng, Y. W., Huang, W., and Coughlin, S. R. (2001) Role of thrombin signalling in platelets in haemo-stasis and thrombosis, Nature 413, 74–78.
30. Grenegard, M., Vretenbrant-Oberg, K., Nylander, M., Desilets, S., Lindstrom, E. G., Larsson, A., Ramstrom, I., Ramstrom, S., and Lindahl, T. L. (2008) The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine, J Biol Chem 283, 18493–18504.
31. Leger, A. J., Covic, L., and Kuliopulos, A. (2006) Protease-activated receptors in cardiovascular diseases, Circulation 114, 1070–1077.
32. Seehaus, S., Shahzad, K., Kashif, M., Vinnikov, I. A., Schiller, M., Wang, H., Madhusudhan, T., Eckstein, V., Bierhaus, A., Bea, F., Blessing, E., Weiler, H., Frommhold, D., Nawroth, P. P., and Isermann, B. (2009) Hypercoagulability inhibits monocyte transen-dothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phospho-inositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability, Circulation 120, 774–784.
33. Kubo, S., Ishiki, T., Doe, I., Sekiguchi, F., Nishikawa, H., Kawai, K., Matsui, H., and Kawabata, A. (2006) Distinct activity of peptide mimetic intracellular ligands (pepducins) for proteinase-activated receptor-1 in multiple cells/tissues, Ann N Y Acad Sci 1091, 445–459.
34. Strande, J. L., Hsu, A., Su, J., Fu, X., Gross, G. J., and Baker, J. E. (2008) Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling, J Pharmacol Exp Ther 324, 1045–1054.
35. Dorsam, R. T., and Gutkind, J. S. (2007) G-protein-coupled receptors and cancer, Nat Rev Cancer 7, 79–94.
36. Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., and Bar-Shavit, R. (1998) Thrombin receptor overexpression in malignant and physiological invasion processes, Nat Med 4, 909–914.
37. Henrikson, K. P., Jazin, E. E., Greenwood, J. A., and Dickerman, H. W. (1990) Prothrombin levels are increased in the estrogen-treated immature rat uterus, Endocrinology 126, 167–175.
38. Rudroff, C., Seibold, S., Kaufmann, R., Zetina, C. C., Reise, K., Schafer, U., Schneider, A., Brockmann, M., Scheele, J., and Neugebauer, E. A. (2002) Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcinoma in vitro, Clin Exp Metastasis 19, 181–189.
39. Nierodzik, M. L., Chen, K., Takeshita, K., Li, J. J., Huang, Y. Q., Feng, X. S., D’Andrea, M. R., Andrade-Gordon, P., and Karpatkin, S. (1998) Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis, Blood 92, 3694–3700.
40. Even-Ram, S. C., Maoz, M., Pokroy, E., Reich, R., Katz, B. Z., Gutwein, P., Altevogt, P., and Bar-Shavit, R. (2001) Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin, J Biol Chem 276, 10952–10962.
41. Nierodzik, M. L., Kajumo, F., and Karpatkin, S. (1992) Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo, Cancer Res 52, 3267–3272.
42. Whitehead, I., Kirk, H., and Kay, R. (1995) Expression cloning of oncogenes by retroviral transfer of cDNA libraries, Mol Cell Biol 15, 704–710.
43. Martin, C. B., Mahon, G. M., Klinger, M. B., Kay, R. J., Symons, M., Der, C. J., and Whitehead, I. P. (2001) The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways, Oncogene 20, 1953–1963.
44. Yang, E., Boire, A., Agarwal, A., Nguyen, N., O’Callaghan, K., Tu, P., Kuliopulos, A., and Covic, L. (2009) Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis, Cancer Res 69, 6223–6231.
45. Agarwal, A., Covic, L., Sevigny, L. M., Kaneider, N. C., Lazarides, K., Azabdaftari, G., Sharifi, S., and Kuliopulos, A. (2008) Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer, Mol Cancer Ther 7, 2746–2757.
46. Kaufmann, R., Oettel, C., Horn, A., Halbhuber, K. J., Eitner, A., Krieg, R., Katenkamp, K., Henklein, P., Westermann, M., Bohmer, F. D., Ramachandran, R., Saifeddine, M., Hollenberg, M. D., and Settmacher, U. (2009) Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion, Carcinogenesis 30, 1487–1496.
47. Bailey, J. M., Mohr, A. M., and Hollingsworth, M. A. (2009) Sonic hedgehog paracrine signaling regulates metastasis and lymphangio-genesis in pancreatic cancer, Oncogene 28, 3513–3525.
48. Theunissen, J. W., and de Sauvage, F. J. (2009) Paracrine Hedgehog signaling in cancer, Cancer Res 69, 6007–6010.